165 related articles for article (PubMed ID: 19636639)
1. Dynamic contrast-enhanced folate-receptor-targeted MR imaging using a Gd-loaded PEG-dendrimer-folate conjugate in a mouse xenograft tumor model.
Chen WT; Thirumalai D; Shih TT; Chen RC; Tu SY; Lin CI; Yang PC
Mol Imaging Biol; 2010 Apr; 12(2):145-54. PubMed ID: 19636639
[TBL] [Abstract][Full Text] [Related]
2. Integrin αvβ3-targeted dynamic contrast-enhanced magnetic resonance imaging using a gadolinium-loaded polyethylene gycol-dendrimer-cyclic RGD conjugate to evaluate tumor angiogenesis and to assess early antiangiogenic treatment response in a mouse xenograft tumor model.
Chen WT; Shih TT; Chen RC; Tu SY; Hsieh WY; Yang PC
Mol Imaging; 2012; 11(4):286-300. PubMed ID: 22954145
[TBL] [Abstract][Full Text] [Related]
3. Folate receptor-targeted fluorescent paramagnetic bimodal liposomes for tumor imaging.
Ding N; Lu Y; Lee RJ; Yang C; Huang L; Liu J; Xiang G
Int J Nanomedicine; 2011; 6():2513-20. PubMed ID: 22072885
[TBL] [Abstract][Full Text] [Related]
4. Biodistribution of a 153 Gd-folate dendrimer, generation = 4, in mice with folate-receptor positive and negative ovarian tumor xenografts.
Konda SD; Wang S; Brechbiel M; Wiener EC
Invest Radiol; 2002 Apr; 37(4):199-204. PubMed ID: 11923642
[TBL] [Abstract][Full Text] [Related]
5. [Folate-poly-L-lysine-Gd-DTPA as MR contrast agent for tumor imaging via folate receptor-targeted delivery].
Yuan Z; Liu SY; Xiao XS; Zhong GR; Jiang QJ
Zhonghua Yi Xue Za Zhi; 2007 Mar; 87(10):673-8. PubMed ID: 17553304
[TBL] [Abstract][Full Text] [Related]
6. Targeting dendrimer-chelates to tumors and tumor cells expressing the high-affinity folate receptor.
Wiener EC; Konda S; Shadron A; Brechbiel M; Gansow O
Invest Radiol; 1997 Dec; 32(12):748-54. PubMed ID: 9406015
[TBL] [Abstract][Full Text] [Related]
7. Folate receptor targeted imaging using poly (ethylene glycol)-folate: in vitro and in vivo studies.
Kim SL; Jeong HJ; Kim EM; Lee CM; Kwon TH; Sohn MH
J Korean Med Sci; 2007 Jun; 22(3):405-11. PubMed ID: 17596645
[TBL] [Abstract][Full Text] [Related]
8. Folate-PEG-appended dendrimer conjugate with α-cyclodextrin as a novel cancer cell-selective siRNA delivery carrier.
Arima H; Yoshimatsu A; Ikeda H; Ohyama A; Motoyama K; Higashi T; Tsuchiya A; Niidome T; Katayama Y; Hattori K; Takeuchi T
Mol Pharm; 2012 Sep; 9(9):2591-604. PubMed ID: 22873579
[TBL] [Abstract][Full Text] [Related]
9. Iron oxide nanoparticles as magnetic resonance contrast agent for tumor imaging via folate receptor-targeted delivery.
Choi H; Choi SR; Zhou R; Kung HF; Chen IW
Acad Radiol; 2004 Sep; 11(9):996-1004. PubMed ID: 15350580
[TBL] [Abstract][Full Text] [Related]
10. A low molecular weight folate receptor targeted contrast agent for magnetic resonance tumor imaging.
Kalber TL; Kamaly N; So PW; Pugh JA; Bunch J; McLeod CW; Jorgensen MR; Miller AD; Bell JD
Mol Imaging Biol; 2011 Aug; 13(4):653-62. PubMed ID: 20809208
[TBL] [Abstract][Full Text] [Related]
11. Intracellular uptake and intracavitary targeting of folate-conjugated liposomes in a mouse lymphoma model with up-regulated folate receptors.
Shmeeda H; Mak L; Tzemach D; Astrahan P; Tarshish M; Gabizon A
Mol Cancer Ther; 2006 Apr; 5(4):818-24. PubMed ID: 16648551
[TBL] [Abstract][Full Text] [Related]
12. MR imaging of ovarian tumors using folate-receptor-targeted contrast agents.
Wang ZJ; Boddington S; Wendland M; Meier R; Corot C; Daldrup-Link H
Pediatr Radiol; 2008 May; 38(5):529-37. PubMed ID: 18357444
[TBL] [Abstract][Full Text] [Related]
13. Tumor imaging using P866, a high-relaxivity gadolinium chelate designed for folate receptor targeting.
Corot C; Robert P; Lancelot E; Prigent P; Ballet S; Guilbert I; Raynaud JS; Raynal I; Port M
Magn Reson Med; 2008 Dec; 60(6):1337-46. PubMed ID: 19025883
[TBL] [Abstract][Full Text] [Related]
14. Synthesis and grafting of thioctic acid-PEG-folate conjugates onto Au nanoparticles for selective targeting of folate receptor-positive tumor cells.
Dixit V; Van den Bossche J; Sherman DM; Thompson DH; Andres RP
Bioconjug Chem; 2006; 17(3):603-9. PubMed ID: 16704197
[TBL] [Abstract][Full Text] [Related]
15. Improved therapeutic activity of folate-targeted liposomal doxorubicin in folate receptor-expressing tumor models.
Gabizon A; Tzemach D; Gorin J; Mak L; Amitay Y; Shmeeda H; Zalipsky S
Cancer Chemother Pharmacol; 2010 May; 66(1):43-52. PubMed ID: 19779718
[TBL] [Abstract][Full Text] [Related]
16. Enhanced tumor detection using a folate receptor-targeted near-infrared fluorochrome conjugate.
Moon WK; Lin Y; O'Loughlin T; Tang Y; Kim DE; Weissleder R; Tung CH
Bioconjug Chem; 2003; 14(3):539-45. PubMed ID: 12757377
[TBL] [Abstract][Full Text] [Related]
17. Folate receptor targeted, rare-earth oxide nanocrystals for bi-modal fluorescence and magnetic imaging of cancer cells.
Setua S; Menon D; Asok A; Nair S; Koyakutty M
Biomaterials; 2010 Feb; 31(4):714-29. PubMed ID: 19822364
[TBL] [Abstract][Full Text] [Related]
18. Folate-PEG-NOTA-Al
Chen Q; Meng X; McQuade P; Rubins D; Lin SA; Zeng Z; Haley H; Miller P; González Trotter D; Low PS
Mol Pharm; 2017 Dec; 14(12):4353-4361. PubMed ID: 29028357
[TBL] [Abstract][Full Text] [Related]
19. Antitumor activity of folate receptor-targeted liposomal doxorubicin in a KB oral carcinoma murine xenograft model.
Pan XQ; Wang H; Lee RJ
Pharm Res; 2003 Mar; 20(3):417-22. PubMed ID: 12669962
[TBL] [Abstract][Full Text] [Related]
20. Folate-linked lipid-based nanoparticles for synthetic siRNA delivery in KB tumor xenografts.
Yoshizawa T; Hattori Y; Hakoshima M; Koga K; Maitani Y
Eur J Pharm Biopharm; 2008 Nov; 70(3):718-25. PubMed ID: 18647651
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]